Search

Search Constraints

You searched for: Author/Creator Bresson, Jean‐Louis

Search Results

1. 'Nutrimune®' and immune defence against pathogens in the gastrointestinal and upper respiratory tracts: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. (30th January 2017)

2. A combination of beta‐sitosterol and beta‐sitosterol glucoside and normal function of the immune system: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. (24th July 2019)

3. A fixed carbohydrate:protein ratio ≤ 1.8 on an energy basis consumed in the context of an energy‐restricted diet and reduction of body weight: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. (13th June 2017)

4. Adequacy and sufficiency evaluation of existing EFSA guidelines for the molecular characterisation, environmental risk assessment and post‐market environmental monitoring of genetically modified insects containing engineered gene drives. (12th November 2020)

5. Affron® and increase in positive mood: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. (2nd July 2021)

6. Animal dietary exposure in the risk assessment of feed derived from genetically modified plants. (19th January 2023)

7. Anxiofit‐1 and reduction of subthreshold and mild anxiety: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. (22nd October 2020)

8. Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis. (24th November 2020)

9. Appropriate age range for introduction of complementary feeding into an infant's diet. (12th September 2019)

10. Assessment of genetically modified cotton 281‐24‐236 × 3006‐210‐23 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐019). (10th November 2022)